The perceived stigma inherent in progressive neurological diseases, such as Alzheimer's dementia (AD) and Parkinson's Disease (PD), has been under-recognized. The purposes of this pilot study were to examine: (1) the psychometric properties of the Stigma Impact (SIS) and Stigma Experience Scales (SES) when used with persons with AD or PD; and (2) differences in perceived stigma by disease diagnosis. The sample included 26 persons with AD and 14 persons with PD. Findings support the reliability of the total SIS scale for both persons with AD or PD. The four SIS subscales had acceptable reliability when used with persons with PD, while two of the four subscales had adequate reliability when used with persons with AD. Internal consistency reliability of the SES was acceptable in PD sample only. Validity of the total SIS scale and the four subscales was supported through significant correlations with mental status (AD sample only), self-esteem, depression, and personal control. Persons with AD scored higher on the SIS internalized shame subscale and lower on personal control compared to persons with PD. Overall, support was found for the SIS as a reliable and valid measure of perceived stigma in persons with AD or PD. The magnitude of perceived stigma in persons with AD is comparable to or greater than other populations of persons with chronic illness, including cancer and PD.
Ahlskog, J.E., & Muenter, M.D. (2001). Frequency of levodopa-related dyskinesias and motor fluctuations estimated from the cumulative literature. Movement Disorders, 16, 448—458.
2.
American Psychiatric Association. (1997). Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Journal of Psychiatry , 154(Supplement 5S), 1—39.
3.
Benbow, S.M., & Reynolds, D. (2000). Challenging the stigma of Alzheimer's disease . Hospital Medicine, 61(3), 174—177.
4.
Bloom, B.S., de Pouvourville, N., & Straus, W.L. (2003). Cost of illness of Alzheimer's disease: How useful are current estimates?The Gerontologist, 43(2), 158—164.
5.
Burgener, S.C. (1999a). Care decisions in irreversible dementia: Who speaks for the patient? Journal ofGerontological Nursing , 25(8), 53—55.
6.
Burgener, S.C. (1999b). Predicting quality of life in caregivers of Alzheimer's patients: The role of support from and involvement with the religious community . Journal of Pastoral Care, 53(4), 433—446.
7.
Burgener, S.C., & Dickerson-Putman, J. (1999). Assessing the patient in the early stages of irreversible dementia: The relevance of patient perspectives. Journal ofGerontological Nursing, 25(2), 33—41.
8.
Burgener, S.C., & Twigg, P. (2002). Relationships among caregiver factors and quality of life in care recipients with irreversible dementia. Journal of Alzheimer's Disease and Related Disorders, 16(2), 88—102.
9.
Burgener, S.C., Twigg, P., & Popovich, A. (2005). Measuring psychological well being in cognitively impaired persons. Dementia: TheInternational Journal of Social Research and Practice, 4(4), 463—485.
10.
Clare, L., Marková, I., Verhey, F., & Kenny, G. (2005). Awareness in dementia: A review of assessment methods and measures. Aging &Mental Health, 9(5), 394—413.
11.
Clare, L., & Wilson, B.A. (2006). Longitudinal assessment of awareness in early-stage Alzheimer's disease using comparable questionnaire-based and performance-based measures: A prospective one-year follow-up study. Aging &Mental Health, 10(2), 156—165.
12.
Clarke, J. (2005). Adverse factors and the mental health of older people: Implications for social policy and professional practice. Journal of Psychiatric and Mental Health Nursing, 12, 290—296.
13.
Crisp, A.H., Gelder, M.G., Rix, S., Meltzer, H.I., & Rowlands, O.J. (2000). Stigmatisation of people with mental illnesses. British Journal of Psychiatry, 177, 4—7.
14.
Cumming, J., & Cumming, E. (1965). On the stigma of mental illness. Community Mental Health Journal, 1, 135—143.
15.
Dashiell, J., & Kirk, T. (1989). Alzheimer's disease: A current perspective. Caring, 8, 5—10.
16.
Depla, M.F., de Graaf, R., van Weeghel, J., & Heeren, T.J. (2005). The role of stigma in the quality of life of older adults with severe mental illness. International Journal of Geriatric Psychiatry, 20, 146—153.
17.
Evans, L., Funkenstein, H.H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., et al. (1989). Prevalence of Alzheimer's disease in a community population: Higher than previously reported. Journal of theAmerican Medical Association, 262, 2552—2556.
18.
Falk, G. (2001). Stigma: How we treat outsiders. Amherst, NY: Prometheus Books.
19.
Fife, B.L., & Wright, E.R. (2000). The dimensionality of stigma: A comparison of its impact on the self of persons with HIV/AIDS and cancer. Journal of Health and Social Behavior, 41, 50—67.
20.
Folstein, M.F., Folstein, S., & McHugh, P.R. (1975). Mini-mental state: A practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatric Research, 12, 189—198.
21.
Goffman, E. (1963). Stigma: Notes on the management of a spoiled identity . Englewood Cliffs, NJ: Prentice Hall.
22.
Harris, P.B., & Sterin, G.J. (1999). Insider's perspective: Defining and preserving the self in dementia. Journal of Mental Health andAging, 5, 241—256.
23.
Hebert, L.E., Scherr, P.A., Bienjas, J.L., Bennett, D.A., & Evans, D.A. (2003). Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Archives of Neurology, 60(8), 1119—1122.
Holston, E.C. (2005). Stigmatization in Alzheimer's disease research on African American elders. Issues in Mental Health Nursing , 26, 1103—1127.
26.
Hughes, C., Berg, L., Danziger, W., Coben, L., & Martin, R. (1982). A new clinical scale for the staging of dementia . British Journal of Psychiatry, 140, 566—572.
27.
Hutchinson, S.A., & Wilson, H.S. (1998). The theory of unpleasant symptoms and Alzheimer's disease . . . including commentary by E.R. Lenz and A.G. Gift. Scholarly Inquiry in Nursing Practice, 12(2), 143—162.
28.
Iliffe, S., DeLepeieire, J., VanHout, H., Kenny, G., Lewis, A., Vernooij-Dassen, M., et al. (2005). Understanding obstacles to the recognition of and response to dementia in different European countries: A modified focus group approach using multinational, multi-disciplinary expert groups. Aging &Mental Health, 9(1), 1—6.
29.
Jolley, D.J., & Benbow, S.M. (2000). Stigma and Alzheimer's disease: Causes, consequences and a constructive approach. International Journal of Clinical Practice, 54(2), 117—119.
30.
Jones, E.E., Farina, A. Hastorf, A., Marksu, H., Mella, D., & Scott , R. (1984). Social stigma: The psychology of a marked relationship. New York: Freeman.
31.
Karlsen, K.H., Tandberg, E., Arsland, D., & Larsen, J.P. (2000). Health related quality of life in Parkinson's disease: A prospective longitudinal study. Neurology, Neurosurgery, &Psychiatry, 69, 584—589.
32.
Kitwood, T. (1997a). Dementia reconsidered. Bristol, PA: Open University Press.
33.
Kitwood, T. (1997b). The experience of dementia. Aging and Mental Health, 1, 13—22.
34.
Koller, W.C. (1992). How accurately can Parkinson's disease be diagnosed . Neurology, 42(Supplement 1), 6—16.
35.
Koller, W.C., & Montgomery, E.B. (1997). Issues in the early diagnosis of Parkinson's disease. Neurology, 49(1), S10—S25.
36.
Larson, E.B., Shadlen, M.-F., Wang, L., McCormick, W.C., Bowen, J.D., Teri, L., et al. (2004). Survival after initial diagnosis of Alzheimer disease. Annals of Internal Medicine, 140, 501—509.
37.
Link, B.G., & Phelan, J.C. (2001, September). On stigma and its public health implications . Paper presented at the National Institutes of Health International Stigma Conference, Bethesda, MD.
38.
Link, B.G., Cullen, F.T., Frank, J., & Wozniack, J.F. (1987). The social rejection of former mental patients: Understanding why labels matter. American Journal of Sociology, 92, 461—500.
39.
Link, B.G., Struening, E., Cullen, F.T., Shrout, P.E., & Donrhenwend, B.P. (1989). A modified labeling theory approach to mental disorders: An empirical assessment. American Sociological Review, 54, 400—423.
40.
Link, B.G., Struening.,E.L., Rahav, M., Phelan, J.C., & Nuttbrock, L. (1997). On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. Journal of Health and Social Behavior, 38, 177—190.
41.
Link, B.G. (1987). Understanding labeling effects in the area of mental disorders: An assessment of the effects of expectations of rejection . American Sociological Review, 52, 96—112.
42.
Lyness, J.M., Noel, T.K., Cox, C., King, D.A., Conwell, Y., & Caine, E.D. (1997). Screening for depression in elderly primary care patients: A comparison of the Center for Epidemiologic Studies Depression Scale and the Geriatric Depression Scale. Archives ofInternal Medicine, 157, 449—454.
43.
MacQuarrie, C.R. (2005). Experiences in early stage Alzheimer's disease: Understanding the paradox of acceptance and denial. Aging &Mental Health, 9, 430—441.
44.
Miles, M.S., Burchinal, D.H., Wasilewski, Y., & Christian, B. (1997). Personal, family, and health-related correlates of depressive symptoms in mothers with HIV. Journal of Family Psychology, 11, 23—34.
45.
Olanow, C.W., Watts, R.L., & Koller, W.C. (2001). An algorithm for the management of Parkinson's disease (2001). Treatment guidelines. Neurology, 56(11, Supplment 5), S1—S88.
46.
Pahwa, R., Lyons, K., McGuire, D., Silverstein, P., Zwiebel, F., Robischon, M., et al. (1997). Comparison of standard carbidopa levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: Pharmacokinetic and quality of life measures. Movement Disorders, 12, 677—681.
47.
Pearlin, L., & Schooler, K. (1978). The structure of coping. Journal of Health and Social Behavior, 19, 2—21.
48.
Pratt, R., Clare, L., & Kirchner, V. (2006). `It's like a revolving door syndrome': Professional perspectives on models of access to services for people with early-stage dementia . Aging & Mental health, 10(1), 55—62.
49.
Reingold, A.L., & Krishnan, S. (2001, September). The study of potentially stigmatizing conditions: An epidemiologic perspective. Paper presented at the National Institutes of Health International Stigma Conference , Bethesda, MD.
50.
Rosenberg, M. (1979). Conceiving the self. New York : Basic Books.
51.
Rosser, R. (1988). A health index and output measure. In S.R. Walker & R.M. Rosser (Eds.), Quality of life: Assessment and application . Lancaster, PA: MT Press.
52.
Sabat, S.R. (2002). Selfhood and Alzheimer's disease. In P.B. Harris (Ed.), The person with Alzheimer's Disease: Pathways to understanding the experience (pp. 88—111). Baltimore, MD: Johns Hopkins Press.
53.
Scheife, R.T., Schumock, G.T., Burstein, A., Gottwald, M.D., & Luer, M.S. (2000). Impact of Parkinson's disease and its pharmacological treatment on quality of life and economic outcomes. American Journal of Health SystemsPharmacology, 57, 953—962.
54.
Small, G.W., Rabins, P.V., Barry, P.P., Buckholtz, N.S., DeKosky, S.T., Ferris, S.H., et al. (1997). Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. Journal of American Medical Association, 278, 1363—1371.
55.
Sontag, S. (1978). Illness as metaphor. New York, NY: McGraw-Hill.
56.
Vernooij-Dassen, M.J., Moniz-Cook, E.D., Woods, R.T., DeLepeieire, J., Leuschner, A., Zanetti, O., et al. (2005). Factors affecting timely recognition and diagnosis of dementia across Europe: From awareness to stigma. International Journal of Geriatric Psychiatry, 20(4), 377—386.
57.
Wahl, O.F. (1999). Telling is risky business. Piscataway, NJ: Rutgers University Press.
58.
Wright, E.R., Gronfein, W.P., & Owens, T.J. (2000). Deinstitutionalization, social rejection, and the self-esteem of former mental patients. Journal of Health and Social Behavior, 41(3), 68—90.
